Constellation Investments’s AbbVie ABBV Stock Holding History

Constellation Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.07M	Buy	36,200 +300	+0.8%	+$16.7K	0.38%	62
2015 Q4	$2.13M	Buy	35,900 +300	+0.8%	+$17.3K	0.4%	57
2015 Q3	$1.94M	Sell	35,600 -1,400	-4%	-$91.1K	0.4%	57
2015 Q2	$2.49M	Buy	37,000 +3,200	+9%	+$209K	0.47%	49
2015 Q1	$1.98M	Buy	33,800 +1,500	+5%	+$90.6K	0.38%	61
2014 Q4	$2.11M	Buy	32,300 +1,400	+5%	+$88.3K	0.43%	51
2014 Q3	$1.78M	Buy	30,900 +600	+2%	+$33.3K	0.4%	53
2014 Q2	$1.71M	Buy	30,300 +500	+2%	+$26.2K	0.4%	52
2014 Q1	$1.53M	Buy	29,800 +600	+2%	+$30.3K	0.37%	59
2013 Q4	$1.54M	Buy	29,200 +2,200	+8%	+$108K	0.39%	58
2013 Q3	$1.21M	Buy	27,000 +1,600	+6%	+$70.9K	0.37%	62
2013 Q2	$1.05M	Buy	+25,400	New	+$1.11M	0.36%	65

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Constellation Investments's ABBV Position: Q1 2016 in Review

Constellation Investments increased its AbbVie (ABBV) stake by 0.84% in Q1 2016, buying an estimated $16.7K and bringing the position to 36,200 shares worth $2.07M. The position accounts for 0.38% of the portfolio, ranked #62.

Constellation Investments first reported a position in ABBV in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.49M in Q2 2015. 1,640 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Constellation Investments held 36,200 shares of AbbVie worth $2.07M as of Q1 2016.
Constellation Investments bought 300 AbbVie shares in Q1 2016, an estimated $16.7K.
AbbVie made up 0.38% of Constellation Investments's portfolio in Q1 2016, its #62 holding.
Constellation Investments first reported a position in AbbVie in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's AbbVie position peaked at $2.49M in Q2 2015.
1,640 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.